KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Buildings (2016 - 2026)

Bristol Myers Squibb has reported Buildings over the past 12 years, most recently at $7.5 billion for Q1 2026.

  • Quarterly Buildings rose 12.74% to $7.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.5 billion through Mar 2026, up 12.74% year-over-year, with the annual reading at $7.3 billion for FY2025, 10.47% up from the prior year.
  • Buildings was $7.5 billion for Q1 2026 at Bristol Myers Squibb, up from $7.3 billion in the prior quarter.
  • Over five years, Buildings peaked at $7.5 billion in Q1 2026 and troughed at $5.7 billion in Q2 2022.
  • The 5-year median for Buildings is $6.5 billion (2023), against an average of $6.5 billion.
  • Year-over-year, Buildings rose 0.09% in 2022 and then grew 12.74% in 2026.
  • A 5-year view of Buildings shows it stood at $5.9 billion in 2022, then increased by 9.71% to $6.5 billion in 2023, then rose by 1.32% to $6.6 billion in 2024, then rose by 10.47% to $7.3 billion in 2025, then rose by 2.97% to $7.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Buildings are $7.5 billion (Q1 2026), $7.3 billion (Q4 2025), and $7.1 billion (Q3 2025).